# NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury

> **NCT04861688** · PHASE3 · COMPLETED · sponsor: **Moleac Pte Ltd.** · enrollment: 182 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **COMBINATION_PRODUCT:** Traditional Chinese Medicine (NeuroAiD II™ (MLC901)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04861688
- **Lead sponsor:** Moleac Pte Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-23
- **Primary completion:** 2023-02-14
- **Final completion:** 2023-02-14
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861688, "NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04861688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*